Yair Herishanu, Neta Goldschmidt, Osnat Bairey, Rosa Ruchlemer, Riva Fineman, Naomi Rahimi-Levene, Lev Shvidel, Tamar Tadmor, Aviv Ariel, Andrea Braester, Mika Shapiro, Erel Joffe, Aaron Polliack and on behalf of the Israeli CLL Study Group (2015) “Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience”, Haematologica. Pavia, Italy, 100(5), pp. 662-669. doi: 10.3324/haematol.2014.115808.